14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MDLN vs HNGE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Hinge Health, Inc. (HNGE) is the stronger overall head-to-head candidate over MDLN (MDLN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MDLN carries a Unified Composite Score of 28.3/100 (SELL) at $39.20 (N/M Forward P/E, N/A operating margin), whereas HNGE carries 39.0/100 (SELL) at $121.04 (35.4x Forward P/E, 18.8% operating margin).
Defensive Composite Rating Caution: Although HNGE compares more favorably head-to-head, both MDLN (28.3/100 SELL) and HNGE (39.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MDLN vs HNGE. Trailing 12-month operating profitability (MDLN N/A vs HNGE 18.8%) and valuation multiples (MDLN N/M vs HNGE 35.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
HNGE Moat ProfileHigh-Margin Pricing Power Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $9.8B market capitalization and 18.8% operating margin.
OpEx & R&D Reinvestment67.0% of Rev ($956M)
90D Engineering Disclosures0 Published
Investor FAQ MDLN vs HNGE Key Questions & Quantitative Answers
As of Nov 16, 2026, Hinge Health, Inc. (HNGE) is the stronger overall head-to-head candidate over MDLN (MDLN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MDLN carries a Unified Composite Score of 28.3/100 (SELL) at $39.20 (N/M Forward P/E, N/A operating margin), whereas HNGE carries 39.0/100 (SELL) at $121.04 (35.4x Forward P/E, 18.8% operating margin). Defensive Composite Rating Caution: Although HNGE compares more favorably head-to-head, both MDLN (28.3/100 SELL) and HNGE (39.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
HNGE leads the Growth & Scale pillar: MDLN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HNGE at +52.4% YoY revenue growth and -68.4% YoY earnings growth on $1.43B TTM revenue (85.8% gross margin, 18.8% operating margin). On trailing 12-month operating scale, MDLN generates N/A in USD-normalized revenue versus $1.43B for HNGE. In operating R&D and SG&A reinvestment, MDLN deploys N/A (0 90-day corporate R&D disclosures) versus 67.0% of Rev ($956M) (0 disclosures) for HNGE.
HNGE screens cheaper on headline valuation multiples. MDLN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HNGE trades at 35.4x Forward P/E, 32.8x Trailing P/E, N/M PEG, and 6.7x EV/Revenue (39.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MDLN (N/A ROE) versus HNGE (47.6% ROE) capital efficiency.
In options market volatility and institutional positioning, MDLN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 74% Vol realized risk). By comparison, HNGE carries 55.0% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 0.81x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (1.14β · 43% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.